Literature DB >> 21848904

Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity.

H S Wik1, T R Enden, A F Jacobsen, P M Sandset.   

Abstract

BACKGROUND: Little is known about the long-term impact of pregnancy-related deep vein thrombosis (DVT) of the lower limbs.
OBJECTIVES: To evaluate the long-term consequences of pregnancy-related DVT by assessment of self-reported, disease-specific quality of life (QOL) and symptom severity using the Venous Insufficiency Epidemiological and Economic Study (VEINES)-QOL/Sym questionnaire, and to investigate the influence of socioeconomic factors and comorbidity. PATIENTS/
METHODS: In this cross-sectional case-control study, 313 women with validated pregnancy-related DVT and 353 controls completed a comprehensive questionnaire, including the disease-specific VEINES-QOL/Sym questionnaire. After exclusion of DVT outside the lower limbs and missing scores, the study population comprised 208 patients and 347 controls. A VEINES-QOL/Sym score < the 25th percentile was defined as a clinically relevant reduced outcome compared with scores ≥ the 50th percentile. Predictors for low scores were identified in multivariate logistic regression models.
RESULTS: Cases reported lower mean VEINES-QOL/Sym scores than controls, 45.6/45.4 vs. 52.8/52.7, respectively (P < 0.001), and QOL among cases was still reduced compared with controls when adjusted for possible confounders. Low education was an independent predictor for both low VEINES-QOL and VEINES-Sym scores, and in addition being married/cohabitating predicted low VEINES-Sym scores.
CONCLUSIONS: Long-term QOL and symptom scores as assessed with the VEINES-QOL/Sym questionnaire were lower in women with previous pregnancy-related DVT than in controls, and also when adjusted for possible confounders. By logistic regression, low education was an independent predictor for low scores. This supports the use of the VEINES-QOL/Sym questionnaire in studies on pregnancy-related DVT.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2011        PMID: 21848904     DOI: 10.1111/j.1538-7836.2011.04468.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  7 in total

1.  Life quality changes within 26 month after the non-surgical treatment in patients with deep vein thrombosis.

Authors:  Ye Tian; Jun Luo; Qiang Cao; Chao Bai; Sairike Magovia
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  A Systematic Review of Quality of Life Measures in Pregnant and Postpartum Mothers.

Authors:  Mulubrhan F Mogos; Euna M August; Abraham A Salinas-Miranda; Dawood H Sultan; Hamisu M Salihu
Journal:  Appl Res Qual Life       Date:  2013-06-01

3.  Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study.

Authors:  Hilde Skuterud Wik; Anne Flem Jacobsen; L Sandvik; P M Sandset
Journal:  BMJ Open       Date:  2012-11-08       Impact factor: 2.692

Review 4.  Do pregnant women have a higher risk for venous thromboembolism following air travel?

Authors:  Morteza Izadi; Mohammad Javad Alemzadeh-Ansari; Davood Kazemisaleh; Maryam Moshkani-Farahani; Akbar Shafiee
Journal:  Adv Biomed Res       Date:  2015-02-23

5.  Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study.

Authors:  Anette Arbjerg Højen; Mette Søgaard; Line Melgaard; Deirdre A Lane; Erik Elgaard Sørensen; Samuel Zachary Goldhaber; Torben Bjerregaard Larsen
Journal:  BMJ Open       Date:  2019-05-14       Impact factor: 2.692

6.  Quality of Life Status and Influencing Factors Among Patients with Deep Vein Thrombosis.

Authors:  Jing Huang; Xiao-Yan Liu; Zhou-Peng Wu; Yu-Kui Ma
Journal:  Patient Prefer Adherence       Date:  2022-04-08       Impact factor: 2.711

Review 7.  Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review.

Authors:  Marc Blondon; Leslie Skeith
Journal:  Front Cardiovasc Med       Date:  2022-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.